Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 0.00 | € 1.40M | € 0.00 | € 2.12M | € 0.00 |
Total Assets | € 80.14M | € 70.99M | € 61.61M | € 63.48M | € 60.91M |
Total Debt | € 0.00 | € 26.05M | € 0.00 | € 23.55M | € 0.00 |
Net Debt | € 0.00 | € 24.65M | € 0.00 | € 21.43M | € 0.00 |
Total Liabilities | € 53.40M | € 40.67M | € 31.19M | € 32.65M | € 33.32M |
Stockholders Equity | € 26.74M | € 30.32M | € 30.43M | € 30.83M | € 27.60M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |